I DIDN'T KNOW WHETHER to laugh, cry, or bang my head against the wall after most of the interviews I did for this issue's cover story (see page 38). Are we really looking at just a few bad apples, or has the whole barrel gone rotten on us when it comes to the integrity of clinical research data? As example after example washed over me — such as the recent suppression of data about the adverse effects of antidepressants and anti-inflammatory pain medications, and the cases of ghost-written ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Bad Apples, you'll also gain access to exclusive premium content.

Already registered? here.